Histological criteria for grading of atypia in melanocytic conjunctival lesions

References

• Shields C L, Hakan D, Karatza E, et al. Clinical survey of 1643 melanocytic and nonmelanocytic conjunctival tumors. Ophthalmology 2004; 111: 1747–1754
   PubMed Web of Science ®Google Scholar
• Eng A M, Rosner M. Conjunctival melanomas. Int J Dermatol 1995; 34: 349–353
   PubMed Web of Science ®Google Scholar
• Folberg R, Jakobiec F A, Bernardino V B, et al. Benign conjunctival melanocytic lesions: clinicopathologic features. Ophthalmology 1989; 96: 436–461
   PubMed Web of Science ®Google Scholar
• Guillen F J, Albert D M, Mihm M C, Jr. Pigmented melanocytic lesions of the conjunctiva – a new approach to their classification. Pathology 1985; 17: 275–280
   PubMed Web of Science ®Google Scholar
• Folberg R, McLean I W, Zimmerman L E. Primary acquired melanosis of the conjunctiva. Hum Pathol 1985; 16: 129–135
   PubMed Web of Science ®Google Scholar
• Seregard S. Conjunctival melanoma. Surv Ophthalmol 1998; 42: 321–350
   PubMed Web of Science ®Google Scholar
• Baum T D, Adamis A P, Jakobiec F A. Primary acquired melanosis of the conjunctiva. Int Ophthalmol Clin 1997; 37: 61–72
   PubMedGoogle Scholar
• Jakobiec F A, Folberg R, Iwamoto T. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology 1989; 96: 147–166
   PubMed Web of Science ®Google Scholar
• Zamir E, Mechoulam H, Micera A, et al. Inflamed juvenile conjunctival naevus: Clinicopathological characterisation. Br J Ophthalmol 2002; 86: 28–30
   PubMed Web of Science ®Google Scholar
• Gloor P, Alexandrakis G. Clinical characterization of primary acquired melanosis. Invest Ophthalmol Vis Sci 1995; 36: 1721–1729
   Web of Science ®Google Scholar
• McLean I W. Differential diagnosis of conjunctival melanoses. Ann Diagn Pathol 1998; 2: 264–270
   PubMedGoogle Scholar
• Folberg R, Jakobiec F A, McLean I W, et al. Is primary acquired melanosis of the conjunctiva equivalent to melanoma in situ. Mod Pathol 1992; 5: 2–5
   PubMed Web of Science ®Google Scholar
• Liesegang T J, Campbell R J. Mayo Clinic experience with conjunctival melanomas. Arch Ophthalmol 1980; 98: 1385–1389
   PubMedGoogle Scholar
• Folberg R, McLean I W, Zimmerman L E. Conjunctival melanosis and melanoma. Ophthalmology 1984; 91: 673–678
   PubMed Web of Science ®Google Scholar
• McDonnell J M, Carpenter J D, Jacobs P, et al. Conjunctival melanocytic lesions in children. Ophthalmology 1989; 96: 986–993
   PubMed Web of Science ®Google Scholar
• Shields C L, Shields J A, Gunduz K, et al. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 2000; 118: 1497–1507
   PubMedGoogle Scholar
• J A Shields, Shields, C L. Atlas of Conjunctival and Eyelid Tumors. Philadelphia, Lippincott Williams and Wilkins. 1999; 243–265
   Google Scholar
• Folberg R, Baron J, Reeves R D, et al. Animal model of conjunctival primary acquired melanosis. Ophthalmology 1989; 96: 1006–1013
   PubMed Web of Science ®Google Scholar
• Folberg R, McLean I W, Zimmerman L E. Malignant melanoma of the conjunctiva. Hum Pathol 1985; 16: 136–143
   PubMed Web of Science ®Google Scholar
• Levi-Schaffer F, Micera A, Zamir E, et al. Nerve growth gactor and eosinophils in inflamed juvenile conjunctival nevus. Invest Ophthalmol Vis Sci 2002; 43: 1850–1856
   PubMed Web of Science ®Google Scholar
• G Massi, LeBoit, P E. Histology of Nevi and Melanoma. Berlin, Springer Verlag. 2004; 337–346
   Google Scholar
• Kornstein M J, Brooks J S, Eider D E. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi. Cancer Res 1983; 43: 2749–2753
   PubMed Web of Science ®Google Scholar
• Sugiura M, Colby K A, Mihm M C, Jr, et al. Conjunctival primary acquired melanosis with atypia: clinicopathologic analysis of 29 cases. Am J Surg Pathol 2007; 31: 185–192
   PubMed Web of Science ®Google Scholar
• Li H, Yeatts P, Sangueza O P. Malignant melanoma arising from PAM without atypia. Am J Dermatopathol 2006; 28: 232
   Google Scholar
• Talve L A, Collan Y U, Ekfors T O. Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin. J Cutan Pathol 1996; 23: 335–343
   PubMed Web of Science ®Google Scholar
• Sparrow L E, English D R, Taran J M, et al. Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors. Am J Dermatopathol 1998; 20: 12–16
   PubMed Web of Science ®Google Scholar
• Sharara N A, Alexander R A, Luthert P J, et al. Differential immunoreactivity of melanocytic lesions of the conjunctiva. Histopathology 2001; 39: 426–431
   PubMed Web of Science ®Google Scholar
• Chowers I, Livni N, Solomon A, et al. MIB-1 and PC-10 immunostaining for the assessment of proliferative activity in primary acquired melanosis without and with atypia. Br J Ophthalmol 1998; 82: 1316–1319
   PubMed Web of Science ®Google Scholar
• Lazzaro B, Elder D E, Rebers A, et al. Immunophenotyping of compound and Spitz nevi and vertical growth-phase melanomas using a panel of monoclonal antibodies reactive in paraffin sections. J Invest Dermatol 1993; 100: 313–7S
   Web of Science ®Google Scholar
• Orchard G. Evaluation of melanocytic neoplasms: application of a pan-melanoma antibody cocktail. Br J Biomed Sci 2002; 59: 196–202
   PubMedGoogle Scholar